WuXi Biologics (Cayman) Inc

HKEX:2269

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WuXi Biologics (Cayman) Inc's stock price target?

Price Target

29.62 HKD

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 29.62 HKD with a low forecast of 12.12 HKD and a high forecast of 65.1 HKD.

What is WuXi Biologics (Cayman) Inc's Revenue forecast?

Projected CAGR

13%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 53%. The projected CAGR for the next 3 years is 13%.

What is WuXi Biologics (Cayman) Inc's Operating Income forecast?

Projected CAGR

16%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 71%. The projected CAGR for the next 3 years is 16%.

What is WuXi Biologics (Cayman) Inc's Net Income forecast?

Projected CAGR

18%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 72%. The projected CAGR for the next 3 years is 18%.